Rigacci, Luigi

Rigacci, Luigi  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 2019 Luminari, Stefano; Donati, Benedetta; Casali, Massimiliano; Valli, Riccardo; Santi, Raffaella; Puccini, Benedetta; Kovalchuk, Sofya; Ruffini, Alessia; Fama, Angelo; Berti, Valentina; Fragliasso, Valentina; Zanelli, Magda; Vergoni, Federica; Versari, Annibale; Rigacci, Luigi; Merli, Francesco; Ciarrocchi, Alessia
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 2020 Staderini, Michela; Mannelli, Lara; Antonioli, Elisabetta; Puccini, Benedetta; Berti, Valentina; Mungai, Francesco; Vergoni, Federica; Carrai, Valentina; Rigacci, Luigi; Bosi, Alberto
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 2012 Rigacci, Luigi; Puccini, B; Dodero, A; Iacopino, P; Castagna, L; Bramanti, S; Ciceri, F; Fanin, R; Rambaldi, A; Falda, M; Milone, G; Guidi, S; Martelli, Mf; Mazza, P; Oneto, R; Bosi, Alberto; Gruppo Italiano Trapianto di Midollo Osseo,
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 2021 Tutino, Francesca; Puccini, Giulia; Linguanti, Flavia; Puccini, Benedetta; Rigacci, Luigi; Kovalchuk, Sofya; Sciagrà, Roberto; Berti, Valentina
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 2019 Rigacci L.; Puccini B.; Broccoli A.; Dona M.; Gotti M.; Evangelista A.; Santoro A.; Bonfichi M.; Re A.; Spina M.; Botto B.; Pulsoni A.; Pagani C.; Stelitano C.; Salvi F.; Nassi L.; Mannelli L.; Kovalchuk S.; Gioia D.; Zinzani P.L.
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 2017 Rigacci, L.; Puccini, B.; Zinzani, P.; Kovalchuk, S.; Broccoli, A.; Evangelista, A.; Gioia, D.; Mannelli, L.; Castagnoli, A.; Santoro, A.; Bonfichi, M.; Rossi, G.; Anastasia, A.; Zaja, F.; Vitolo, U.; Pavone, V.; Pulsoni, A.; Gaidano, G.; Stelitano, C.; Salvi, F.; Rusconi, C.; Tani, M.; Freilone, R.; Borsatti, E.; Levis, A.
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 2014 Di Gioia, M; Innocenti, C; Donnini, I; Nozzoli, C; Bosi, A; Guidi, S; Rigacci, L; Repice, A; Massacesi, L; Portaccio, E; Amato, MP; Saccardi, R
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 2017 Fornaro, Alessandra; Olivotto, Iacopo; Rigacci, Luigi; Ciaccheri, Mauro; Tomberli, Benedetta; Ferrantini, Cecilia; Coppini, Raffaele; Girolami, Francesca; Mazzarotto, Francesco; Chiostri, Marco; Milli, Massimo; Marchionni, Niccolò; Castelli, Gabriele
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 2018 Calistri, Linda; Puccini, Benedetta; Berti, Valentina; Grazzini, Giulia; Nardi, Cosimo; Rigacci, Luigi; Colagrande, Stefano
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 2017 Cencini, Emanuele; Fabbri, Alberto; Rigacci, Luigi; Lazzi, Stefano; Gini, Guido; Cox, Maria Christina; Mancuso, Salvatrice; Abruzzese, Elisabetta; Kovalchuk, Sofia; Goteri, Gaia; Di Napoli, Arianna; Bono, Roberto; Fratoni, Stefano; Di Lollo, Simonetta; Bosi, Alberto; Leoncini, Lorenzo; Bocchia, Monica
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 2012 Carrai, V; Miniati, I; Guiducci, Serena; Capaccioli, G; Alterini, R; Saccardi, Riccardo; Conforti, Ml; Rigacci, Luigi; Rotunno, G; Bosi, Alberto; Cerinic, Mm
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 2014 Rigacci, Luigi; Puccini, Benedetta; Kovalchuk, Sofia; Fabbri, Elisa; Bonizzoni, Erminio; Perrone, Tania; Bosi, Alberto
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 2019 Rinaldi F.; Giache S.; Spinicci M.; Corsi P.; Ambu S.; Gianfaldoni G.; Rigacci L.; Arena U.; Bartoloni A.; Zammarchi L.
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 2014 Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E.
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 2008 Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 2019 Ambrosio M.R.; Lazzi S.; Bello G.L.; Santi R.; Del Porro L.; de Santi M.M.; Guazzo R.; Mundo L.; Rigacci L.; Kovalchuck S.; Onyango N.; Fabbri A.; Cencini E.; Zinzani P.L.; Zaja F.; Angrilli F.; Stelitano C.; Cabras M.G.; Spataro G.; Bob R.; Menter T.; Granai M.; Cevenini G.; Naresh K.N.; Stein H.; Sabattini E.; Leoncini L.
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 2020 Rigacci L.; Annibali O.; Kovalchuk S.; Bonifacio E.; Pregnolato F.; Angrilli F.; Vitolo U.; Pozzi S.; Broggi S.; Luminari S.; Merli F.; Spina M.; Bolis S.; Margiotta-Casaluci G.; Scalzulli R.; Cox C.; Mamusa A.M.; Santoro A.; Zinzani P.L.; Ferrari S.; Gini G.; Vigliotti M.L.; Mule A.; Flenghi L.
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 2011 Napoli C; Nobili S; Landini I; Perrone G; Valenti A; Brugia M; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 2010 Napoli C; Nobili S; Landini I; Perrone G; Puccini B; Antognoli G; Doria M; Martelli M; Finolezzi E; Rigacci L; Di Lollo S; Bosi A; Mini E